Evox is investing significant resources to capitalise on advances made within protein production and our exosome manufacturing lines rely on some of the latest technologies for cell line development, cell culturing, exosome harvesting, and exosome purification. We also focus on optimising the formulation and pharmaceutical compositions for exosome administration, to ensure that we harness the biology and the potency of exosomes as efficiently as possible.